Kevin Osterhoudt, MD, MSCE, FAAP, FACMT, is an attending physician in the Division of Emergency Medicine and the medical director of the Poison Control Center at The Children’s Hospital of Philadelphia (CHOP) and is professor of Pediatrics at The Children’s Hospital of Philadelphia and the University of Pennsylvania School of Medicine. Dr. Osterhoudt is an Associate Fellow for the Center for Injury Prevention and Research at CHOP, and is an Associate Scholar in the Center for Global Health and a faculty member in the Community Outreach and Education Core of the Center of Excellence in Environmental Toxicology at Penn. He has co-authored over 100 journal articles and textbook chapters and serves on the editorial boards of Pediatric Emergency Care and Clinical Toxicology. Dr. Osterhoudt is a co-author of the AAP’s 2016 policy statement on preventing lead poisoning in children. He is also an internationally recognized clinical expert on childhood lead poisoning consulting on cases throughout the U.S. and in other countries such as Kosovo, Vietnam, and Mexico.
He has served nationally on the Board of Directors of the American College of Medical Toxicology, as the American Board of Pediatrics’ representative to the medical toxicology sub-board, and on the Executive Committee of the Council on Environmental Health of the American Academy of Pediatrics. He is currently a member of the Executive Committee of the AAP’s Council on Injury, Violence, and Poisoning Prevention and a member of CHOP’s new PRCCEH. Dr. Osterhoudt’s academic interests include the clinical epidemiology and risk assessment of pediatric poisoning exposures, and methemoglobinemia disorders during infancy.
- Become an informed lead environmental health advocate for their community
- Teach families the meaning and context of the CDC’s new blood lead reference value of 3.5 mcg/dL
- Consider the position of childhood lead poisoning, as a social determinant of health, within CHOP’s Healthier Together Initiative
This seminar was delivered as a Pediatric Grand Rounds Lecture at Children’s Hospital of Philadelphia, on September 13, 2023.
The work presented in the presentations, videos, and other content on this site (“Presentations”) includes publicly available medical evidence, a consensus of medical practitioners, and/or opinions of individual practitioners that may differ from consensus opinions. These Presentations are intended only to provide general information and need to be adapted for each specific patient based on the practitioner’s professional judgment, consideration of any unique circumstances, the needs of each patient and their family, the availability of various resources at the health care institution where the patient is located, and other factors. The Presentations are not intended to constitute medical advice or treatment, nor should they be relied upon as such. The Presentations are not intended to create a doctor-patient relationship between/among The Children’s Hospital of Philadelphia, its physicians and the individual patients in question. The information contained in these Presentations are general in nature, and do not and are not intended to refer to specific patients.
CHOP, The Children’s Hospital of Philadelphia Foundation and its or their affiliates, the authors, presenters, practitioners, editors, and others associated with the creation of the Presentations (“CHOP”) are not responsible for errors or omissions in the Presentations; for any outcomes a patient might experience where a clinician reviewed one or more such Presentations in connection with providing care for that patient; and/or for any and all third party content on the site or in the Presentations. CHOP makes no warranty, expressed or implied, with respect to the currency, completeness, applicability or accuracy of the Presentations. Application of the information in or to a particular situation remains the professional responsibility of the practitioner who is directly treating the patient.
To the extent that the Presentations include information regarding drug dosing, in view of ongoing research, changes in government regulations and the constant flow of information relating to drug therapy and drug reactions, the viewer should not rely on the Presentation content, but rather is urged to check the package insert for each drug for indications, dosage, warnings and precautions.
Some drugs and medical devices presented in the Presentations have United States Food and Drug Administration (FDA) clearance for limited use in restricted research settings. It is the responsibility of the practitioner to ascertain the FDA status of each drug or device planned for use in their clinical practice.
You shall indemnify, defend and hold harmless CHOP, The Children’s Hospital of Philadelphia Foundation, and its/their current and former employees, officers, and agents, trustees, and their respective successors, heirs and assigns (“Indemnitees”) against any claims, liability, damage, loss or expenses (including attorneys’ fees and expenses of litigation) in connection with any claims, suits, actions, demands or judgments arising directly or indirectly out of your reference to or use of the Presentations.
The Presentations are protected by copyright laws and in some cases patent laws, and all rights are reserved under such laws. No part of the Presentations may be reproduced in any form by any means, or utilized in any other way, absent prior written permission from the copyright owner.
By starting this module, you agree to our Content Disclaimer and Terms of Service.